Pilar de la Rocha

Intratumoral Immune Cell Infiltrates, FoxP3, and Indoleamine 2,3-Dioxygenase in Patients with Melanoma Undergoing CTLA4 Blockade

B. Comin-Anduix, A. Ribas, A. Cochran, 2009, Clinical Cancer Research.

A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four α-Fetoprotein Peptides

A. Ribas, L. Butterfield, R. Finn, 2006, Clinical Cancer Research.

A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides.

A. Ribas, L. Butterfield, R. Finn, 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma

B. Comin-Anduix, A. Ribas, L. Camacho, 2008, Journal of Translational Medicine.

Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824.

F. Marincola, A. Ribas, E. Wang, 2009, Cancer Research.

Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma

F. Marincola, B. Comin-Anduix, A. Ribas, 2009, Clinical Cancer Research.

Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824.

F. Marincola, A. Ribas, E. Wang, 2009, Cancer research.